GENDER-WISE STUDIES OF BACTERIAL OTITIS MEDIA IN PATIENTS WITH HEARING LOSS

Main Article Content

Rizwana Khanzada
Abid Hussain
Abdul Aziz Shaikh
Muhammad Khan
Jehangir Kazi
Agha Asad Noor
Marvi

Keywords

Gender, Bacterial otitis media, Hearing loss

Abstract

Background: Ear is very sensitive hearing organ of the body having three parts; the outer, middle and the inner year. It is more exposed to the outer environment that possesses allergens, microorganisms, water, air, sweat etc. Most significantly infectious agents, the microorganisms when enter in to the ear by any source cause mild to severe infection, which may lead to the hearing defects such as partial of permanent hearing loss irrespective to any age or sex. The hearing loss may occur by different factors like hereditary and contaminated environmental factors that include allergies, cold, infection of sinuses, accumulation of mucous and exposure to household and cigarette smoke. Mostly, the patients are suffering from otitis media; middle ear’s infection which leads to the inner ear infection followed by hearing loss, if left untreated.


Objectives: (1) To observe the frequency of infection, (2) to determine the common pathogens of otitis media among the male and female patients of different age groups, (3) to determine the incidence rate of otitis media and hearing loss and (4) to observe the effective treatment by antibiotic profiling.


Study Design: Prospective study.


Place and Duration of Study: Outpatient Departments (OPD) of different hospitals and Department of ENT Liaquat University of Medical & Health Sciences (LUMHS), Jamshoro, Sindh Pakistan, from 1st January 2016 to 31st December 2018.


Methodology: Two hundred and seventy-three ear swab specimens were screened and only 187 positive cases were found. Four classes of patients of hearing loss were studied such as hereditary hearing loss (HHL), infected non-hearing loss (INHL), infected hearing loss (IHL) and the patients with inflamed year.


Results: There were 103 males and 84 females positive (infected) patients of different age groups mainly of IHL. The samples collected from males were greater (61) in number as compared to the females (45) with infection rate (%) of 51%, 45%, 4% and 41%, 36%, 62% in male and female patients of 3-11, 12-25 and 26-40 years of age. The main bacterial isolates were Staphylococcus aureus 23%, Streptococcus pneumoniae 14%, E. coli 16.5%, Klebsiella pneumoniae 8%, Pseudomonas aeruginosa 18% and Proteus mirabilis 7% and in females 20%, 10%, 12%, 12%, 17%, 4% respectively. The number of clinical isolates from all specimen ranged n=81, n=64, n=63, n=54, n=36 and n=20 of Staphylococcus aureus, E. coli, Pseudomonas aeruginosa, Streptococcus pneumonia, Proteus mirabilis and Klebsiella pneumoniae respectively. The greater resistance was observed by Staphylococcus aureus to methicillin 90%, penicillin, 42%; Streptococcus pneumoniae to gentamycin 31%, penicillin 30%; E.coli to Ciprofloxacin 28%, Ofloxacn 25%; Klebsiella pneumoniae to chloramphenicol 28%, ampicillin 22%; Pseudomonas aeruginosa to levofloxacin 22%, amoxicillin 21%, norfloxacin 21% and Proteus mirabilis to amoxicillin 30.5%, cephalosporin 28%, cefoxitin 22%.


Conclusion: The otitis media and the otitis media with effusion mainly in the patients of infected hearing loss greatly in children and elderly age mainly caused by bacterial isolates with the multidrug resistance (MDR) capability. The existence of MDR isolates is distressing that could be harmful and increase to the high resistance to other antibiotics that may lead more fatal incidences of chronic otitis (COM) media and COM with effusion.

Abstract 130 | pdf Downloads 24

References

1. Ansari A, Tariq MA, Sadiq NM. Histology, ear. StatPearls. Treasure Island, FL: StatPearls Publishing; 2022.
2. Meherali S, Campbell A, Hartling L, Scott S. Understanding parents' experiences and information needs on pediatric acute otitis media: a qualitative study. J Patient Exp 2019; 6(1):53-61.
3. Ubukata K, Morozumi M, Sakuma M, Takata M, Mokuno E, Tajima T, et al. Etiology of acute otitis media and characterization of pneumococcal isolates after introduction of 13-valent pneumococcal conjugate vaccine in japanese children. Pediatr Infect Dis J 2018;37(6):598-604.
4. Ubukata K, Morozumi M, Sakuma M, Adachi Y, Mokuno E, Tajima T, et al. Genetic characteristics and antibiotic resistance of haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan. J Infect Chemother 2019;25(9):720-26.
5. Protasova IN, Per'yanova OV, Podgrushnaya TS. Acute otitis media in the children: etiology and the problems of antibacterial therapy. Vestn Otorinolaringol 2017;82(2):84-9.
6. Usonis V, Jackowska T, Petraitiene S, Sapala A, Neculau A, Stryjewska I, et al. Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries. BMC Pediatr 2016;16:108.
7. Schilder AG, Chonmaitree T, Cripps AW, Rosenfeld RM, Casselbrant ML, Haggard MP, et al. Otitis media. Nat Rev Dis Primers 2016;2(1):16063.
8 Rajat P, Deepak J, Negi V, Pal S, Adekhandi S, Sharma M, et al. Microbiology of Chronic Suppurative Otitis Media in a Tertiary Care Setup of Uttarakhand State, India. N Am J Med Sci 2013; 5(4): 282-7.
9. Fabian U, Matuba F, Reimer A, Paul M, Matuschek E, Thegerstrom J, et al. Aerobic bacteria associated with chronic suppurative otitis media in Angola. Infec Diseases Poverty 2018; 1(42): 1-10.
10. Achariya T. Modified oxidase test (microdase): principle, procedure and uses. Microbe 2015.
11. Shields P, Cathcart L. Oxidase test protocol. Am Soc Microbiol 2016; 11: 39-43.
12. Reiner K. Catalase test protocol. Am Soc Microbiol 2016; 18: 43-7.
13 Dahal P. Nitrate reduction test: principle, procedure and results. Microbes Notes 2024; 9: 13-7.
14. Davis R, Pezzlo M. Phenylalanine deaminase test. Am Soc Microbiol 2023; 17: 391-8.
15. Koome B. Lysne decarboxylase test: principle, procedure and results. Microbiology 2023; 18: 54-7.
16. Mansoor T, Musani MA, Khalid G, Kamal M. Pseudomonas aeruginosa in chronic suppurative otitis media: sensitivity spectrum against various antibiotics in Karachi. J Ayub Med Coll Abbottabad 2009; 21(2):120-23.
17. Poorey VK, Lyer A. Study of bacterial flora in chronic suppurative otitis media and its clinical significance. Indian J. Otolaryngol. Head Neck Surg 2002; 54(2): 91-5.
18. Abusi CN, Ologe FE. Pathogenic agent of chronic suppurative otitis media Dorin. Nigeria East Afr Med J 2002; 9(4):202-5.
19. Melaku A, Lulseged S. Chronic suppurative otitis media in children's hospital in Addis Ababa. Ethiopia Ethiop Med J 1999;37:237-46.
20. Ako-Nai AK, Oluga FA, Onipede AO, Adejuyigbe EA, Arnusa, YB. The characterization of bacterial isolates from acute otitis media in Ile-Ife. South­ Western Nigeria J Trop Pediatr 2002;48(1):15-23.
21. Tanon-Anoh MJ, Kacou-Ndouba A, Yoda M, Ette-Akre E, Sanogo D, Kouassi B. Particularities of bacterial ecology of acute otitis media in an African subtropical country (Cote D'Ivoire). Int J Pediatr Otorhinolaryngol 2006; 70(5): 817-22.
22. Gifford KA, Holmes MG, Bernstein HH. Hearing loss in children. Pediatr Rev 2009; 30 (6): 207-16.
23. Krug E, Cieza A, Chadha S, Sminkey L, Martinez R, Stevens GA, et al. Childhood hearing loss act now, here's how! World Health Organization 1-13. WHO Document Production Services, Geneva, Switzerland, 2020.
24. Simon A, Nghiem LD, Le-Clech P, Khan SJ, Drewes JE. Effects of membrane degradation on the removal of pharmaceutical!y active compounds (PhACs) by NF/RO filtration processes. J Membrane Sci 2009; 340(1-2): 16-25.
25 Odonkor ST, Addo KK. Bacteria resistance to antibiotics: recent trends and challenges. Int J Biol Med Res 2011; 2(4): 1204-10.
26. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1(2):101-4.
27. Andersson DI. Persistence of antibiotic resistant bacteria. Curr Opin Microbial 2003; 6(5): 452-6.
28. Enne VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001; 357(9265): 1325-8.

Most read articles by the same author(s)